My role is to act like a catalyst

Nikhil Chopra recently took over as CEO and Whole-time Director of JB Chemicals & Pharmaceuticals. In a free-wheeling conversation with the Express Pharma team, he describes how he will take forward the legacy brands as well as build new ones

- Nikhil Chopra

Viveka Roychowdhury: Could you give us an overview of your brief at JB Chemicals and Pharmaceuticals (JBCPL) as their CEO, post their acquisition by PE firm KKR?

It’s a privilege to be a part of the JBCPL family. I have worked in the pharmaceutical industry for more than two decades and joined JBCPL around four months back. The organisation has done tremendously well over the last four decades and I intend to make the best use of our manufacturing set up along with the strong legacy that the company has established. We have a fantastic asset and we will leverage it to get the best out of the manufacturing capabilities and strong legacy. I am delighted to share that as reported by IMS – JBCPL enjoys five brands in the top 300 as a franchise, a feat achieved by a limited number of companies, which demonstrates the strength of the company.

Our robust manufacturing is primarily based in the southern part of Gujarat where we have a set up in Panoli, Ankleshwar (Bharuch Dist.) and Daman. In the area of lozenges, we have a sizeable and differential opportunity to service our many multinational clients.

I would like to take this opportunity to thank the promoters of JBCPL for their everlasting support in ensuring a seamless transition and helping us further enhance our relationship with external stakeholders. JBCPL has an able leadership team and talent who have been with the company for more than a decade, which put together lays a strong foundation for the company.